Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
QuintilesIMS
Farmers Insurance
Express Scripts
Novartis
McKesson
UBS
Teva
Cipla

Generated: January 19, 2018

DrugPatentWatch Database Preview

GABAPENTIN Drug Profile

« Back to Dashboard

Which patents cover Gabapentin, and what generic alternatives are available?

Gabapentin is a drug marketed by Actavis Elizabeth, Alkem, Amneal Pharms Ny, Apotex Inc, Aurobindo Pharma Ltd, Cspc Ouyi Pharm Co, Epic Pharma Llc, Hikma, Invagen Pharms, Jiangsu Hengrui Med, Marksans Pharma, Mylan, Sandoz, Sciegen Pharms Inc, Sun Pharm Inds Ltd, Sun Pharm Industries, Taro Pharm, Teva Pharms, Watson Labs, Acella Pharms Llc, Amneal Pharms, Hi Tech Pharma, Taro, Tris Pharma Inc, Aci Healthcare Ltd, Alkem Labs Ltd, Glenmark Pharms Ltd, Hikma Pharms, Ivax Sub Teva Pharms, Mylan Pharms Inc, Ranbaxy, Teva, Teva Pharms Usa, and Zydus Pharms Usa Inc. and is included in forty-six NDAs.

The generic ingredient in GABAPENTIN is gabapentin. There are twenty-eight drug master file entries for this compound. One hundred and nine suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the gabapentin profile page.

US Patents and Regulatory Information for GABAPENTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth GABAPENTIN gabapentin TABLET;ORAL 075694-002 Oct 21, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz GABAPENTIN gabapentin TABLET;ORAL 076120-002 Jan 27, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz GABAPENTIN gabapentin CAPSULE;ORAL 075428-003 Jan 24, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Marksans Pharma GABAPENTIN gabapentin CAPSULE;ORAL 090007-002 Jul 21, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hikma Pharms GABAPENTIN gabapentin TABLET;ORAL 078782-001 Jul 21, 2011 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Ltd GABAPENTIN gabapentin CAPSULE;ORAL 077242-002 Aug 24, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Zydus Pharms Usa Inc GABAPENTIN gabapentin TABLET;ORAL 078926-001 Feb 11, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms GABAPENTIN gabapentin CAPSULE;ORAL 075435-003 Oct 8, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sciegen Pharms Inc GABAPENTIN gabapentin CAPSULE;ORAL 204989-003 Feb 18, 2016 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz GABAPENTIN gabapentin TABLET;ORAL 076877-002 Jul 6, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
AstraZeneca
Argus Health
McKinsey
UBS
Chubb
Cerilliant
Federal Trade Commission
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot